Cargando...

Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors

BACKGROUND: Both endometrial cancer and postmenopausal breast cancer risk are increased by obesity and higher endogenous estrogen levels. While aromatase inhibitors reduce breast cancer incidence, their influence on endometrial cancer is uncertain. METHODS: We addressed this issue in a cohort of 17,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Chlebowski, Rowan T., Schottinger, Joanne E., Shi, Jiaxiao, Chung, Joanie, Haque, Reina
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565775/
https://ncbi.nlm.nih.gov/pubmed/25757699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29332
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!